.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Mar 18, 2026MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery...
Mar 10, 2026MiniMed Group, Inc. (MiniMed), a global leader in full stack insulin delivery, today announced CE (Conformité Européenne) Mark for use of the MiniMed™ 780G system with the Instinct sensor,...
Mar 9, 2026MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000 shares of its common stock at a price to the public...
- Mar 6, 2026
MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (Nasdaq) today under the symbol "MMED" in connection with...
- Mar 5, 2026
MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial public offering (IPO) of 28,000,000 shares of its common stock at a...
Feb 25, 2026Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global...
- Feb 24, 2026
MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced that it has launched a roadshow for the initial public offering (IPO) of 28,000,000 shares of...
Feb 2, 2026Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexibility for people living with type 1 and...
Jan 12, 2026MiniMed Go™ is the first and only smart MDI system that automatically integrates insulin dosing and glucose data in a single app to provide empowering insights for individuals on multiple daily injectionsMedtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its MiniMed Go™ app. The MiniMed Go™ Smart Multiple...
- Jan 7, 2026
A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range...
- Jan 7, 2026Pharmacy Benefit agreements expand portfolio coverage to simplify access for eligible customers and providers
Medtronic Diabetes today announced the expansion of U.S. pharmacy formulary access for its MiniMed™ 780G insulin pump, through agreements with major pharmacy benefit managers (PBMs) and PBM...
Dec 19, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a...
- Dec 5, 2025
Medtronic plc, a global leader in healthcare technology, today announced that Ryan Weispfenning, vice president and head of investor relations, has elected to join its Diabetes business to...
Dec 2, 2025Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott...
Sep 16, 2025After three years, most insulin was delivered automatically by the system, and those who used the recommended optimal settings experienced the greatest benefits.GALWAY, Ireland – September 16 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today presented compelling real-world evidence demonstrating that the MiniMed™ 780G...
- Sep 11, 2025
Medtronic plc, a global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 61st...
Sep 2, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system...
- Jul 21, 2025
Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by...
- Jul 8, 2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended...
Jun 18, 2025Medtronic plc, a global leader in healthcare technology, is partnering with professional tennis player Alexander Zverev and his foundation to elevate global awareness of type 1 diabetes. Through...
Jun 12, 2025Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the intended separation. The name honors the...
- May 21, 2025Enables intense focus on highest margin growth drivers where Medtronic has leading core competencies
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This...
- Apr 24, 2025
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an...
Apr 18, 2025Latest approval expands Medtronic CGM portfolio in the U.S.Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for the Simplera Sync™ sensor for use with the...
Mar 20, 2025Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.Medtronic plc, a global leader in medical technology, presented today the first real-world data on the use of its latest Smart MDI system, which combines the InPen™ smart insulin pen with the...
- Mar 6, 2025The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetes
Medtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming 18th International Conference on Advanced Technologies and...
Nov 20, 2024New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses.Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance for its new InPen™ app featuring missed meal dose...
- Nov 18, 2024With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.
Medtronic, a global leader in healthcare technology, today shared new clinical and real-world evidence on the MiniMed™ 780G system from the Asia Pacific region demonstrating its ability to...
- Nov 7, 2024New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.
Medtronic plc, a global leader in medical technology, announced new clinical and real-world data to be presented at the inaugural Asian Conference on Innovative Therapies for Diabetes Management...
Oct 4, 2024Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issueMedtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700...
- Sep 4, 2024The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
Medtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 60th...
- Aug 7, 2024Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) —...
- Jun 21, 2024With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that...
Jun 4, 2024Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technologyMedtronic, a global leader in healthcare technology, today announced that Dr. Goran Petrovski M.D., Ph.D. has joined the company’s Diabetes Operating Unit as Medical Affairs Director. Dr....
- Jun 3, 2024
Medtronic, a global leader in medical technology, today announced an overview of its upcoming presence at the American Diabetes Association's (ADA) 84th Scientific Sessions. Following the one-year...
- Apr 30, 2024Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy.
Medtronic, a global leader in healthcare technology, today announced the results of the randomized controlled Closed- loop insulin delivery in pregnant women with type 1 diabetes: a randomized...
- Apr 23, 2024Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems.
Medtronic, a global leader in healthcare technology, shared results from separate studies highlighting that the Medtronic MiniMed™ 780G system is a cost-effective therapy option for people...
- Feb 22, 2024Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*
Medtronic plc, the global leader in medical technology, announced the unveiling of new data on its MiniMed™ 780G system at the upcoming 17th International Conference on Advanced Technologies and...
Jan 31, 2024Actress, writer and producer Alexandra Park, best known for her role on The Royals and Australian series Home and Away, is partnering with Medtronic Diabetes to help others living with type 1...
Jan 8, 2024With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for the MiniMed™ 780G system with Simplera Sync™, a disposable,...
- Nov 8, 2023New guidelines will expand access to automated insulin delivery technology among wider population.
Medtronic plc, the leading global healthcare technology company, applauds the guidance* published by the National Institute for Health and Care Excellence (NICE) in the United Kingdom recommending...
Oct 5, 2023Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.Medtronic plc (NYSE:MDT), a global leader in medical technology, presented multi-continent real-world data demonstrating that use of the MiniMed™ 780G system allows people living with diabetes...
- Sep 25, 2023The company will initiate a phased launch of its disposable SimpleraTM CGM at the meeting, its smallest and most comfortable CGM to-date that’s integrated with the InPenTM smart insulin pen
DUBLIN – September 25, 2023 – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its participation in the upcoming European Association for the Study of...
- Jul 6, 2023Orders will be processed immediately and shipments will start in the coming weeks
DUBLIN – July 6, 2023 – Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today that its MiniMed™ 780G system with the new Guardian™ 4 sensor requiring no...
- Jun 23, 2023
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets,...
Jun 23, 2023Results show that the use of InPen resulted in an increase in Time in Range among those in the studiesDUBLIN – June 23, 2023 – Medtronic plc (NYSE:MDT), the global leader in medical technology, presented an oral presentation and a late-breaking poster on its InPen™ Smart Insulin Pen (SIP)....
- May 25, 2023Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has entered into a set of definitive agreements to acquire EOFlow Co. Ltd. (KOSDAQ: 294090), manufacturer of...
- May 2, 2023
Today, Medtronic Canada announced that it has received a licence from Health Canada for the Guardian™ 4 sensor to be used in conjunction with the MiniMed™ 780G insulin pump system† for the...
- Apr 25, 2023Resolution follows the recent FDA approval of the MiniMed™ 780G system featuring the world's first and only automated insulin delivery system with real-time meal detection technology*
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) lifted the warning letter received at the company's Diabetes...
- Apr 21, 2023Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its MiniMed™ 780G system with the Guardian™ 4 sensor...
- Feb 24, 2023A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced one-year data from the ADAPT study (n=82), the first multi-national randomized controlled study comparing the...
- Feb 16, 2023
Medtronic plc, the global leader in medical technology, today announced its participation in the upcoming 16th International Conference on Advanced Technologies and Treatments for Diabetes (ATTD)...
Dec 9, 2022Medtronic Canada is pleased to announce Health Canada has licensed the Medtronic Extended infusion set — the first and only infusion set that can be worn for up to 7 days with Medtronic insulin...
- Nov 15, 2022Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. launch of Medtronic Extended infusion set, the first and only infusion set labelled for up to 7-day...
Nov 1, 2022The MiniMed 780G system is the only insulin pump that automatically adjusts and corrects every five minutes to help keep sugar levels in rangeMedtronic Canada is pleased to announce that it has received a license from Health Canada for its MiniMed™ 780G system for people living with type 1 diabetes. This system with advanced hybrid...
Oct 18, 2022Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's...
Sep 1, 2022First-of-its-kind study demonstrates individuals using the Medtronic system achieved 1.4% absolute reduction in A1c and 27.6% absolute increase in Time in RangeMedtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced results from the Medtronic ADAPT study were published in The Lancet Diabetes & Endocrinology. The ADAPT study is...
Sep 1, 2022Combination of InPen™ smart insulin pen system integrated with Guardian™ 4 CGM helps people with diabetes on multiple daily injections (MDI) stay ahead of their glucose levelsi,iiToday Medtronic announced the European launch of its Smart MDI system, which combines personalized insulin dosing information from the InPen™ smart insulin pen with the power of predictive...
Aug 3, 2022Former Disney Channel Actress Shares How the Medtronic InPen™ system Helps Her Balance Demands of Dual CareerActress Jennifer Stone, best known for her role on the Disney Channel’s “Wizards of Waverly Place”, will be partnering with Medtronic Diabetes to help others living with type 1 diabetes...
Jun 4, 2022This week, Medtronic is presenting new MiniMed™ 780G system real-world data from Europe and Chile and clinical data at the American Diabetes Association (ADA) 82nd Scientific Sessions. The...
- May 31, 2022Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatre
Medtronic plc, the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 82nd scientific sessions virtual meeting, June 3-7, 2022....
- Apr 27, 2022Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Medtronic reported study results from the extended study phase of its MiniMed™ 780G system[i] pivotal trial with new data using its no-calibration, non-adjunctive Guardian™ 4 sensor[ii]. The...
- Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
Apr 20, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
Mar 14, 2022Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for continuous glucose monitoring (CGM), a key diabetes technology has been recently expanded or...
- Dec 22, 2021Medicare coverage for Medtronic customers will be available 60 days after official publication
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand Medicare coverage for all types of...
- Dec 15, 2021
Medtronic plc (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company's Northridge, California, facility, the...
- Oct 19, 2021Harder to manage pediatric and adolescent patients achieve 74% Time in Range, and 82% overnight Time in Range, well surpassing clinical consensus guidelines for glycemic control
Medtronic plc (NYSE: MDT), a leading global healthcare technology company, recently announced one-year, real-world clinical data on 3,211 pediatric and adolescent patients with type 1 diabetes 15...
- Jun 28, 2021Data Were Presented at the American Diabetes Association 81st Scientific Sessions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The...
- Jun 23, 2021Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June...
- Jun 2, 2021Results Demonstrate 76% Time in Range and 94% Time in Advanced Hybrid Closed Loop Mode
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 4,120 individuals on the MiniMed™ 780G system, a small subset of those on the...
- Jun 1, 2021Data on the Company's Holistic Portfolio Will Include Real-World Data on MiniMed™ 780G System and New Data on Medtronic Continuous Glucose Monitoring Systems and Extended-Wear Infusion Set
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its virtual participation at the 14th International Conference on Advanced Technologies & Treatments for Diabetes...
- May 26, 2021New No Fingerstick1 Sensor Integrates with Both the MiniMed 780G System and the Smart InPen System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Mark for expanded functionality of the company's InPen™ smart2 insulin pen for...
Apr 14, 2021Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set that can...
- Apr 7, 2021New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes. The company committed...
- Nov 12, 2020Real-Time Glucose Data Coupled with InPen's Dose Calculator Helps Users Make Better Dosing Decisions
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of InPen™ integrated with real-time1 Guardian Connect™ CGM data. InPen is the first and only...
- Sep 1, 2020New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2
DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
- Aug 11, 2020
DUBLIN and SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of privately-held Companion...
- Jul 9, 2020
DUBLIN and SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Tandem Diabetes Care, Inc. (NASDAQ:TNDM) today announced that they have entered into a non-exclusive patent...
- Jun 13, 2020
DUBLIN, June 13, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data on its extended wear infusion set presented at the virtual 80th...
- Jun 12, 2020Investment with Blackstone Life Sciences Expected to Accelerate Medtronic Diabetes Pump and CGM Technology Pipeline
DUBLIN and NEW YORK, June 12, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) and Blackstone (NYSE:BX) today announced that Medtronic intends to significantly increase research and development...
- Jun 12, 2020Data from Two Key Clinical Trials of the Next-Generation Medtronic Automated Insulin Pump Demonstrates Positive Results for Patients with Type 1 Diabetes
DUBLIN, June 12, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today presented results from its U.S. pivotal trial of its investigational MiniMed™...
- Jun 11, 2020Next Generation Closed Loop Insulin Pump System Features Auto-Correction Algorithm and Bluetooth Connectivity
DUBLIN, June 11, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced CE (Conformité Européenne) Marking of its MiniMed™ 780G system, a...
- Jun 9, 2020Medtronic to Release New Data on Advanced Hybrid Closed-Loop Systems and Extended-Wear Infusion Set
DUBLIN, June 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association 80th scientific...
- May 22, 2020
DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™...
- May 6, 2020Medtronic Expands Diabetes Support Programs to Help Customers Losing Insurance Coverage Due to Job Loss as a Result of COVID-19
DUBLIN, May 06, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced an expansion of the Medtronic Assurance program with a new option to...
- Apr 30, 2020Sensors, Infusion Sets and Reservoirs Donated to Organization Will Support Continuity of Therapy for People with Diabetes on Pump Therapy Experiencing Financial Hardships Due to COVID-19
DUBLIN, April 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a $1 million product donation to Insulin for Life USA to support...
- Feb 24, 2020Positive Data on Many Medtronic Innovations Presented at ATTD: Extended Wear Infusion Set Designed to Last Twice as Long, MiniMed™ 670G System Real-Life Performance in Europe, and ProCGM Use in Type 2 Diabetes Patients
DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a successful conclusion to the 13th International Conference on...
- Dec 17, 2019Acquisition Strengthens Development of Personalized Closed Loop Technology for Diabetes Management
DUBLIN, Dec. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has completed the acquisition of Klue, a software company focused on...
- Oct 21, 2019
DUBLIN, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that Sean Salmon, previously Senior Vice President (SVP) and President, Coronary and Structural Heart (CSH)...
Sep 18, 2019DUBLIN, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions today announced real-world clinical outcomes on European...
- Sep 17, 2019Next-Generation Professional CGM Combines Valuable Data with Optimal User Experience
DUBLIN, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced the Envision™ Pro Continuous Glucose...
Sep 16, 2019The New Collaboration Aims to Develop Solutions Enabling Dosing Data from Novo Nordisk Smart Insulin Pens to be Shared with Medtronic Continuous Glucose Monitoring DevicesDUBLIN and BAGSVÆRD, Denmark, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), and Novo Nordisk A/S today announced a collaboration that will develop solutions to integrate insulin...
- Sep 9, 2019
DUBLIN, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it has secured reimbursement for the...
- Aug 16, 2019Experimental Infusion Set Aims to Address Patient Burden with Comfort and Convenience Features for Insulin Pump Therapy
DUBLIN, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it received investigational approval from the U.S. Food and Drug...
- Aug 14, 2019Strategic Partnership Marks First Agreement in New York to Incorporate Patient Engagement Program Aimed at Improving Diabetes Management
DUBLIN – August 14, 2019 – Medtronic plc (NYSE:MDT), the global leader in medical technology, and Capital District Physicians' Health Plan, Inc. (CDPHP) today announced an innovative...
- Jul 23, 2019
DUBLIN, July 23, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced its Premarket Approval (PMA) submission to the...
- Jun 10, 2019Sugar.IQ Insights Viewed as Helpful and Enable Users to Avoid Diabetes-Related Events up to Four Hours in Advance
DUBLIN and SAN FRANCISCO - June 10, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world data on its Guardian(TM) Connect continuous glucose...
- Jun 8, 2019
DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has initiated the company's pivotal trial for its next-generation Guardian(TM)...
- Jun 8, 2019
DUBLIN - June 8, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the enrollment of the first study participants in the company's pivotal trial of its...